Provides for a credit insurance policy for the indemnification of an intended parent for expenses disbursed when either the intended parent or a person acting as surrogate receives in-vitro fertilization or intrauterine insemination treatment that fails and does not result in the birth of a child.
Summary
S00698 would amend New York’s insurance law to expressly allow a form of credit insurance tied to reproductive and family-building arrangements. The bill adds a new category of indemnification for an intended parent when in-vitro fertilization (IVF) or intrauterine insemination (IUI) treatment fails and does not result in the birth of a child. Covered expenses may include certain medical and hospital costs, insurance cost-sharing amounts, living expenses, travel expenses, and other lawful expenses associated with the treatment.
The bill also updates existing insurance-law language related to adoption and surrogacy by replacing older references such as “birth mother” with “gestational parent” and clarifying definitions used in the statute. It requires insurers, or an excess line broker acting on their behalf, to disclose prominently that this credit insurance is not a substitute for comprehensive health insurance. The bill would take effect 30 days after becoming law.
Impact
If enacted, the bill would expand section 1113 of the Insurance Law and add a new section 3437 governing disclosures for IVF/IUI-related credit insurance. It would create explicit statutory authority for insurers to offer policies that indemnify intended parents for certain financial losses tied to failed fertility treatment, while also imposing a consumer-warning requirement to prevent confusion with health coverage. The measure would affect insurers, excess line brokers, intended parents, and potentially surrogates or other participants in assisted reproduction arrangements.
Sentiment
No committee transcript or vote record was provided, so there is no documented floor or committee sentiment to assess. Based on the bill text and caption, the measure appears supportive of people pursuing assisted reproduction and intended to address financial risk associated with fertility treatment failures. The overall tone of the legislation is permissive and consumer-protective rather than restrictive.
Contention
The main policy issue is whether insurance products should be authorized to cover losses from failed IVF or IUI treatment, and how far such coverage should extend. Potential points of concern include the scope of reimbursable expenses, the use of credit insurance for medical-related losses, and whether the product could be misunderstood as health insurance despite the required disclaimer. The bill also reflects a broader terminology update in family-law-related insurance provisions, which may be notable to stakeholders focused on surrogacy and adoption language.
Same As
Provides for a credit insurance policy for the indemnification of an intended parent for expenses disbursed when either the intended parent or a person acting as surrogate receives in-vitro fertilization or intrauterine insemination treatment that fails and does not result in the birth of a child.
Provides for a credit insurance policy for the indemnification of an intended parent for expenses disbursed when either the intended parent or a person acting as surrogate receives in-vitro fertilization or intrauterine insemination treatment that fails and does not result in the birth of a child.
Surrogacy; child born via surrogacy required to be relinquished directly to an intended parent, probate courts required to confirm identity of intended parents, State Department of Human Resources authorized to adopt rules
Creates an in vitro fertilization treatment tax credit for up to three cycles of in vitro fertilization treatment for expenses related to treatment for infertility.
Creates an in vitro fertilization treatment tax credit for up to three cycles of in vitro fertilization treatment for expenses related to treatment for infertility.